November 9, 2024: Study Finds Ozempic May Lead to Muscle Loss A new study published in The Lancet medical journal found that semaglutide, the active ingredient in Ozempic, may lead to a higher rate of muscle mass loss compared with caloric-restricted weight loss
A 12-year-old receives the same target dose as an adult
His dedication to innovation and continuing education has solidified his reputation as a leading expert in aesthetic surgery, specializing in breast surgery, body contouring, facial procedures, and non-invasive treatments
Abdurrachim D, Teo XQ, Woo CC, Chan WX, Lalic J, Lam CSP, et al
Although insomnia is not listed as a typical side effect in semaglutides prescribing information, some individuals may experience sleep disturbances, potentially related to the drugs influence on the central nervous system or its gastrointestinal side effects